Literature DB >> 15529356

Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever.

Arturo Diaz1, Chunbo Hu, Daniel L Kastner, Philip Schaner, Anthony M Reginato, Neil Richards, Deborah L Gumucio.   

Abstract

OBJECTIVE: To investigate the expression of the familial Mediterranean fever (FMF) gene (MEFV) in human synovial fibroblasts.
METHODS: MEFV messenger RNA in synovial fibroblasts, chondrocytes, and peripheral blood leukocytes (PBLs) was analyzed by semiquantitative and real-time polymerase chain reaction and ribonuclease protection assay. The subcellular localization of pyrin, the MEFV product, was determined in transfected synovial fibroblasts and HeLa cells with plasmids encoding pyrin isoforms. Native pyrin was detected with an antipyrin antibody.
RESULTS: MEFV was expressed in synovial fibroblasts, but not in chondrocytes. Four alternatively spliced transcripts were identified: an extension of exon 8 (exon 8ext) resulting in a frameshift that predicts a truncated protein lacking exons 9 and 10, the addition of an exon (exon 4a) predicting a truncated protein at exon 5, the in-frame substitution of exon 2a for exon 2, and the previously described removal of exon 2 (exon 2Delta). Exon 8ext transcripts represented 27% of the total message population in synovial fibroblasts. All other alternatively spliced transcripts were rare. Consensus and alternatively spliced transcripts were induced by lipopolysaccharide in synovial fibroblasts and PBLs. In transfected cells, the proteins encoded by all highly expressed splice forms were cytoplasmic. In contrast, native pyrin was predominantly nuclear in synovial fibroblasts, neutrophils, and dendritic cells, but was cytoplasmic in monocytes.
CONCLUSION: Several MEFV transcripts are expressed and inducible in synovial fibroblasts. A prominent isoform lacks the C-terminal domain that contains the majority of mutations found in patients with FMF. While recombinant forms of all major pyrin isoforms are cytoplasmic, native pyrin is nuclear in several cell types. Thus, mechanisms in addition to splicing patterns must control pyrin's subcellular distribution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529356     DOI: 10.1002/art.20600

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Authors:  Jae Jin Chae; Young-Hun Cho; Geun-Shik Lee; Jun Cheng; P Paul Liu; Lionel Feigenbaum; Stephen I Katz; Daniel L Kastner
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

2.  Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility.

Authors:  David S Hains; Xi Chen; Vijay Saxena; Evan Barr-Beare; Weisi Flemming; Robert Easterling; Brian Becknell; George J Schwartz; Andrew L Schwaderer
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

3.  The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.

Authors:  Jae Jin Chae; Geryl Wood; Seth L Masters; Katharina Richard; Grace Park; Brian J Smith; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

Review 4.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 5.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

6.  1Novel MEFV transcripts in Familial Mediterranean fever patients and controls.

Authors:  Myrna Medlej-Hashim; Nancy Nehme; Eliane Chouery; Nadine Jalkh; André Megarbane
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

7.  The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment.

Authors:  Jae Jin Chae; Geryl Wood; Katharina Richard; Howard Jaffe; Nona T Colburn; Seth L Masters; Deborah L Gumucio; Nitza G Shoham; Daniel L Kastner
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

8.  Familial Mediterranean fever with a single MEFV mutation: where is the second hit?

Authors:  Matthew G Booty; Jae Jin Chae; Seth L Masters; Elaine F Remmers; Beverly Barham; Julie M Le; Karyl S Barron; Steve M Holland; Daniel L Kastner; Ivona Aksentijevich
Journal:  Arthritis Rheum       Date:  2009-06

Review 9.  Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.

Authors:  Jae J Chae; Ivona Aksentijevich; Daniel L Kastner
Journal:  Br J Haematol       Date:  2009-05-14       Impact factor: 6.998

10.  Pyrin Modulates the Intracellular Distribution of PSTPIP1.

Authors:  Andrea L Waite; Philip Schaner; Neil Richards; Banu Balci-Peynircioglu; Seth L Masters; Susannah D Brydges; Michelle Fox; Arthur Hong; Engin Yilmaz; Daniel L Kastner; Ellis L Reinherz; Deborah L Gumucio
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.